<DOC>
	<DOC>NCT00681798</DOC>
	<brief_summary>The purpose of this study is to define th Maximum Tolerated Dose (MTD) and the recommended dose (RD) of ZD6474 in combination with a fixed standard dose of gemcitabine and capecitabine</brief_summary>
	<brief_title>Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Confirmed diagnosis of locally advanced unresectable or metastatic pancreatic adenocarcinoma ECOG performance status &lt;1 Measurable disease Severe or uncontrolled systemic disease Clinically significant cardiac event such as myocardial infarction Any concomitant medication that may cause OTc prolongation, include Torsades de Pointes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>pancreatic adenocarcinoma</keyword>
	<keyword>pancreas cancer</keyword>
	<keyword>dose escalation study</keyword>
	<keyword>locally advanced unresectable pancreatic adenocarcinoma</keyword>
	<keyword>Zactima</keyword>
	<keyword>Vandetanib</keyword>
	<keyword>ZD6474</keyword>
</DOC>